Principal Investigator
Philip Harvey
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241301
Clinical Trial Summary
A multicenter, pragmatic study to evaluate clinical effectiveness, engagement with the study app, healthcare resource utilization, and safety of an investigational digital therapeutic (CT-155) in patients
with experiential negative symptoms of schizophrenia
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Anabela Cieslicki
Phone Number
+1 (305) 2434859
Email
axc1623@miami.edu